Biller Jonathan sold VRTX
February 25, 2026 · Form 4 insider transaction
Biller Jonathan sold 945 shares of Vertex Pharmaceuticals Incorporated at $486.35 per share, a transaction worth $459.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
945
Price
$486.35
Total value
$459.6K
InsiderBiller Jonathan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 25, 2026
Filing dateFebruary 26, 2026
Shares owned after13,659
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025.